Last December 2019, a cluster of
viral pneumonia cases identified as
coronavirus disease 2019 (COVID-19) was reported in Wuhan, China. We aimed to explore the frequencies of nasal symptoms in patients with
COVID-19, including
loss of smell and taste, as well as their presentation as the first symptom of the disease and their association with the severity of
COVID-19. In this retrospective study, 1206 laboratory-confirmed
COVID-19 patients were included and followed up by telephone one month after discharged from Tongji Hospital, Wuhan. Demographic data, laboratory values, comorbidities, symptoms, and numerical rating scale scores (0-10) of nasal symptoms were extracted from the hospital medical records, and confirmed or reevaluated by the telephone follow-up. From patients (n=1172) completing follow-up, 199 (17%) subjects had severe
COVID-19 and 342 (29.2%) reported nasal symptoms. 20.6%
COVID-19 patients had
loss of taste (median score=6), while 11.4% had
loss of smell (median score=5).
Loss of taste scores, but not
loss of smell scores, were significantly increased in severe vs. non-severe
COVID-19 patients.
Interleukin (IL)-6 and
lactose dehydrogenase (LDH) serum levels were positively correlated with
loss of taste scores. About 80% of
COVID-19 patients recovered from smell and
taste dysfunction in 2 weeks. In this cohort, only 1 out of 10 hospital admitted patients had
loss of smell while 1 out of 5 reported
loss of taste which was associated to severity of
COVID-19. Most patients recovered smell and taste dysfunctions in 2 weeks.